Advanced Immunotherapy Treatment for Lymphoma and Leukemia Gains Ground at Penn State Cancer Institute

Chimeric antigen receptor (CAR) T-cell therapy boosts survival rates for relapsed and refractory cancer patients.

Boosting Outcomes for Head and Neck Cancers

Penn State Health is first in the region to employ the da Vinci SP to offer improved outcomes for patients with head and neck cancers.

Lifelong Care for Congenital Heart Disease at Penn State Health

The children’s hospital treats patients with congenital heart disease for both the heart defect and any sequelae of their condition.

Penn State Health Children’s Hospital: Pioneers in Pediatric Cardiac Care

Providers at Penn State Health Children’s Hospital constantly innovate to treat pediatric congenital heart disease (CHD). The multidisciplinary care provided at the Complex Fetal Care Center complements their work.

Personalized Post-Op Care for Pediatric Heart Disease

Providers in the Pediatric Cardiac Intensive Care Unit at Penn State Health Children’s Hospital deliver postoperative care to the patient while also preparing families to transition to care at home.